Nuveen’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $770M | Buy |
1,989,863
+29,158
| +1% | +$10.8M | 0.18% | 99 |
|
|
2026
Q1 | $574M | Sell |
1,960,705
-14,612
| -0.7% | -$4.8M | 0.16% | 115 |
|
|
2025
Q4 | $692M | Buy |
1,975,317
+27,199
| +1% | +$9.19M | 0.18% | 101 |
|
|
2025
Q3 | $629M | Buy |
1,948,118
+38,805
| +2% | +$12.1M | 0.17% | 109 |
|
|
2025
Q2 | $743M | Buy |
1,909,313
+93,185
| +5% | +$37.5M | 0.21% | 91 |
|
|
2025
Q1 | $790M | Sell |
1,816,128
-206,235
| -10% | -$82.8M | 0.24% | 73 |
|
|
2024
Q4 | $746M | Sell |
2,022,363
-586,581
| -22% | -$245M | 0.21% | 82 |
|
|
2024
Q3 | $1.36B | Sell |
2,608,944
-291,527
| -10% | -$156M | 0.38% | 42 |
|
|
2024
Q2 | $1.57B | Buy |
2,900,471
+205,075
| +8% | +$108M | 0.46% | 30 |
|
|
2024
Q1 | $1.4B | Sell |
2,695,396
-198,606
| -7% | -$98.8M | 0.41% | 42 |
|
|
2023
Q4 | $1.36B | Sell |
2,894,002
-39,854
| -1% | -$18.4M | 0.44% | 39 |
|
|
2023
Q3 | $1.28B | Sell |
2,933,856
-209,548
| -7% | -$95M | 0.45% | 38 |
|
|
2023
Q2 | $1.4B | Buy |
3,143,404
+56,204
| +2% | +$25.9M | 0.49% | 33 |
|
|
2023
Q1 | $1.42B | Sell |
3,087,200
-55,081
| -2% | -$26.2M | 0.53% | 30 |
|
|
2022
Q4 | $1.61B | Sell |
3,142,281
-203,783
| -6% | -$103M | 0.62% | 27 |
|
|
2022
Q3 | $1.52B | Buy |
3,346,064
+166,290
| +5% | +$79.6M | 0.62% | 25 |
|
|
2022
Q2 | $1.53B | Buy |
3,179,774
+781,362
| +33% | +$387M | 0.59% | 26 |
|
|
2022
Q1 | $1.14B | Buy |
2,398,412
+49,782
| +2% | +$22.8M | 0.37% | 53 |
|
|
2021
Q4 | $1.09B | Sell |
2,348,630
-132,059
| -5% | -$55.6M | 0.32% | 60 |
|
|
2021
Q3 | $925M | Sell |
2,480,689
-37,546
| -1% | -$14.3M | 0.28% | 74 |
|
|
2021
Q2 | $961M | Sell |
2,518,235
-64,040
| -2% | -$24.5M | 0.29% | 73 |
|
|
2021
Q1 | $927M | Sell |
2,582,275
-173,970
| -6% | -$55.9M | 0.29% | 68 |
|
|
2020
Q4 | $885M | Buy |
2,756,245
+771,338
| +39% | +$237M | 0.3% | 65 |
|
|
2020
Q3 | $533M | Sell |
1,984,907
-286,198
| -13% | -$77M | 0.21% | 101 |
|
|
2020
Q2 | $597M | Sell |
2,271,105
-58,304
| -3% | -$15.6M | 0.24% | 89 |
|
|
2020
Q1 | $529M | Buy |
2,329,409
+306,729
| +15% | +$83.6M | 0.26% | 83 |
|
|
2019
Q4 | $611M | Buy |
2,022,680
+615,781
| +44% | +$169M | 0.23% | 91 |
|
|
2019
Q3 | $338M | Sell |
1,406,899
-124,323
| -8% | -$34.1M | 0.14% | 153 |
|
|
2019
Q2 | $432M | Buy |
1,531,222
+1,501,948
| +5,131% | +$410M | 0.17% | 117 |
|
|
2019
Q1 | $8.4M | Sell |
29,274
-551
| -2% | -$159K | 0.04% | 441 |
|
|
2018
Q4 | $7.83M | Sell |
29,825
-47,148
| -61% | -$13M | 0.05% | 428 |
|
|
2018
Q3 | $21.1M | Buy |
76,973
+718
| +0.9% | +$186K | 0.11% | 288 |
|
|
2018
Q2 | $18.2M | Buy |
76,255
+1,132
| +2% | +$262K | 0.11% | 276 |
|
|
2018
Q1 | $16.5M | Sell |
75,123
-492
| -0.7% | -$116K | 0.11% | 283 |
|
|
2017
Q4 | $17M | Buy |
75,615
+25,462
| +51% | +$5.42M | 0.11% | 284 |
|
|
2017
Q3 | $9.52M | Sell |
50,153
-33,839
| -40% | -$6.44M | 0.06% | 405 |
|
|
2017
Q2 | $15.8M | Sell |
83,992
-25,530
| -23% | -$4.59M | 0.1% | 299 |
|
|
2017
Q1 | $18.1M | Sell |
109,522
-22,201
| -17% | -$3.53M | 0.11% | 262 |
|
|
2016
Q4 | $18.9M | Sell |
131,723
-56,881
| -30% | -$7.62M | 0.1% | 257 |
|
|
2016
Q3 | $23.6M | Sell |
188,604
-1,777
| -0.9% | -$229K | 0.14% | 179 |
|
|
2016
Q2 | $25M | Sell |
190,381
-4,752
| -2% | -$650K | 0.15% | 167 |
|
|
2016
Q1 | $27.1M | Buy |
195,133
+2,833
| +1% | +$379K | 0.14% | 151 |
|
|
2015
Q4 | $26.8M | Sell |
192,300
-238
| -0.1% | -$32.8K | 0.14% | 161 |
|
|
2015
Q3 | $27M | Buy |
192,538
+6,656
| +4% | +$1M | 0.15% | 160 |
|
|
2015
Q2 | $30.5M | Buy |
185,882
+24,433
| +15% | +$3.9M | 0.16% | 157 |
|
|
2015
Q1 | $24.9M | Buy |
161,449
+15,514
| +11% | +$2.21M | 0.14% | 212 |
|
|
2014
Q4 | $18.3M | Buy |
145,935
+45,619
| +45% | +$5.64M | 0.1% | 271 |
|
|
2014
Q3 | $12M | Buy |
100,316
+5,858
| +6% | +$672K | 0.07% | 344 |
|
|
2014
Q2 | $10.2M | Sell |
94,458
-5,245
| -5% | -$540K | 0.06% | 374 |
|
|
2014
Q1 | $9.93M | Sell |
99,703
-4,683
| -4% | -$424K | 0.06% | 358 |
|
|
2013
Q4 | $9.64M | Buy |
104,386
+24,471
| +31% | +$2.17M | 0.06% | 364 |
|
|
2013
Q3 | $6.68M | Buy |
79,915
+35,672
| +81% | +$3.06M | 0.04% | 457 |
|
|
2013
Q2 | $3.62M | Buy |
+44,243
| New | +$3.31M | 0.02% | 590 |
|
Other funds holding ELV
Nuveen's ELV Position: Q2 2026 in Review
Nuveen increased its Elevance Health (ELV) stake by 1.5% in Q2 2026, buying an estimated $10.8M and bringing the position to 1,989,863 shares worth $770M. The position accounts for 0.18% of the portfolio, ranked #99.
Nuveen first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.61B in Q4 2022. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Nuveen held 1,989,863 shares of Elevance Health worth $770M as of Q2 2026.
- Nuveen bought 29,158 Elevance Health shares in Q2 2026, an estimated $10.8M.
- Elevance Health made up 0.18% of Nuveen's portfolio in Q2 2026, its #99 holding.
- Nuveen first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- Nuveen's Elevance Health position peaked at $1.61B in Q4 2022.
- 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.